Bcl-2 associated with positive symptoms of schizophrenic patients in an acute phase
- PMID: 23998360
- DOI: 10.1016/j.psychres.2013.08.032
Bcl-2 associated with positive symptoms of schizophrenic patients in an acute phase
Abstract
B cell lymphoma protein-2 (Bcl-2) may contribute to the pathophysiology of schizophrenia in the brain. The aim of this study was to investigate the serum levels of Bcl-2 in schizophrenic patients in an acute phase, and evaluate Bcl-2 level changes after antipsychotic treatment. We consecutively enrolled 41 schizophrenia patients in an acute phase; 28 were followed up with a 4-week antipsychotic treatment. Serum Bcl-2 levels were measured with assay kits. All patients were evaluated by examining the correlation between Bcl-2 levels and Positive and Negative Syndrome Scale (PANSS) scores, using Pearson correlation coefficients. In schizophrenic patients in an acute phase, positive PANSS subscores were significantly negatively correlated with Bcl-2 levels. In addition, we found Bcl-2 levels had a significantly negative correlation with PANSS total scores and positive subscores in male patients in an acute phase. Using the paired t-test, we found no significant changes in Bcl-2 levels in schizophrenia patients who had received the 4-week treatment with antipsychotic drugs (n=28). In conclusion, our results suggest that Bcl-2 might be an indicator of schizophrenia severity in the acute phase. In addition, Bcl-2 levels might be associated with positive symptoms in male patients with schizophrenia.
Keywords: Antipsychotics; Bcl-2; PANSS; Paliperidone; Schizophrenia.
© 2013 Published by Elsevier Ireland Ltd.
Similar articles
-
Changes in oxidative stress markers in patients with schizophrenia: the effect of antipsychotic drugs.Psychiatry Res. 2013 Oct 30;209(3):284-90. doi: 10.1016/j.psychres.2013.01.023. Epub 2013 Mar 14. Psychiatry Res. 2013. PMID: 23497820
-
[Changes in positive and negative symptoms, general psychopathology in schizophrenic patients during augmentation of antipsychotics with glycine: a preliminary 10-week open-label study].Psychiatr Pol. 2011 Nov-Dec;45(6):825-37. Psychiatr Pol. 2011. PMID: 22335126 Polish.
-
Fasting insulin serum levels and psychopathology profiles in male schizophrenic inpatients treated with olanzapine or risperidone.Neuro Endocrinol Lett. 2013;34(4):322-8. Neuro Endocrinol Lett. 2013. PMID: 23803867
-
Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?J Clin Psychiatry. 1999;60 Suppl 5:23-9; discussion 30. J Clin Psychiatry. 1999. PMID: 10192404 Review.
-
A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia.CNS Drugs. 2016 Jan;30(1):27-39. doi: 10.1007/s40263-015-0308-1. CNS Drugs. 2016. PMID: 26801655 Review.
Cited by
-
Dissecting the Epigenetic Changes Induced by Non-Antipsychotic Mood Stabilizers on Schizophrenia and Affective Disorders: A Systematic Review.Front Pharmacol. 2020 Apr 22;11:467. doi: 10.3389/fphar.2020.00467. eCollection 2020. Front Pharmacol. 2020. PMID: 32390836 Free PMC article.
-
Brain-derived neurotrophic factor and glutathione peroxidase as state biomarkers in alcohol use disorder patients undergoing detoxification.Medicine (Baltimore). 2020 Apr;99(17):e19938. doi: 10.1097/MD.0000000000019938. Medicine (Baltimore). 2020. PMID: 32332675 Free PMC article.
-
miRNA-Coordinated Schizophrenia Risk Network Cross-Talk With Cardiovascular Repair and Opposed Gliomagenesis.Front Genet. 2020 Mar 4;11:149. doi: 10.3389/fgene.2020.00149. eCollection 2020. Front Genet. 2020. PMID: 32194626 Free PMC article.
-
Analytical Value of Cell-Free DNA Based on Alu in Psychiatric Disorders.Front Psychiatry. 2020 Jan 21;10:992. doi: 10.3389/fpsyt.2019.00992. eCollection 2019. Front Psychiatry. 2020. PMID: 32038328 Free PMC article.
-
Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive Garcinia mangostanaLinn. (Mangosteen) Pericarp for Schizophrenia.Clin Psychopharmacol Neurosci. 2019 May 31;17(2):297-307. doi: 10.9758/cpn.2019.17.2.297. Clin Psychopharmacol Neurosci. 2019. PMID: 30905130 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical